- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 96.59M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 96.49M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 96.98M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $3.4M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $2.43M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $91.03M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $307.51M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $306.72M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $528.5M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $543.45M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $50.36M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $49.04M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $188.65M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $186.92M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $431.11M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $450.09M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $755.87M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $770.96M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.16 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.25 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.16 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.25 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $17.29M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $17.32M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$15.74M |
| Net Income | Q1 2026 · Mar 31, 2025 | $24.29M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$8.36M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $38.31M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $12.06M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $58.94M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $42.18M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $65.49M |
| Revenue | Q1 2026 · Mar 31, 2026 | $54.24M |
| Revenue | Q1 2026 · Mar 31, 2025 | $124.42M |